Top Markets
Coin of the day
Merck & Co., Inc. Merck & Co., Inc.

Merck & Co., Inc.

MRK
株式のランク #40
Merck & Co., Inc. is a global healthcare leader with operations spanning two... Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This division also develops vital preventive vaccines for pediatric, adolescent, and adult populations. Meanwhile, the Animal Health segment focuses on the research, development, manufacturing, and marketing of veterinary medications, vaccines, and comprehensive health management solutions for animals. This division further provides innovative digital products designed for animal identification, traceability, and continuous monitoring. Merck's extensive clientele encompasses drug wholesalers, pharmacies, hospitals, and government agencies. It also serves managed healthcare organizations, including health maintenance organizations (HMOs) and pharmacy benefit managers, as well as various other institutional clients. Additionally, the company supplies products to individual physicians and their distributors, veterinarians, and livestock producers. The organization actively engages in strategic collaborations with companies such as AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., Ridgeback Biotherapeutics, and Gilead Sciences, Inc. These partnerships are specifically aimed at the joint development and commercialization of prolonged-acting therapies for HIV. Established in 1891, Merck & Co., Inc. maintains its corporate headquarters in Kenilworth, New Jersey.
株価
$152.37
時価総額
$376.33B
変化(1日)
12.46%
変化(1年)
79.41%
US
取引 Merck & Co., Inc. (MRK)

カテゴリー

Merck & Co., Inc.(MRK)のP/B比率
August 2026 時点のP/B比率 TTM: 8.01
Merck & Co., Inc. の最新の財務報告および株価によると、現在のP/B比率(TTM)は 8.01 です。2024 年末時点でのP/B比率は 5.44 でした。
Merck & Co., Inc. の P/B 比率の履歴(2000 ~ 2026)
各年末時点のP/B比率
P/B比率 変化
2026 (TTM) 8.01 57.64%
2025 5.08 -6.51%
2024 5.44 -28.09%
2023 7.56 23.82%
2022 6.11 20.29%
2021 5.08 -34.85%
2020 7.79 -9.22%
2019 8.59 21.37%
2018 7.07 67.90%
2017 4.21 9.48%
2016 3.85 22.74%
2015 3.14 -0.75%
2014 3.16 12.54%
2013 2.81 25.96%
2012 2.23 11.14%
2011 2.01 2.50%
2010 1.96 57.27%
2009 1.24 -62.32%
2008 3.30 -50.09%
2007 6.61 28.29%
2006 5.16 39.08%
2005 3.71 -5.78%
2004 3.93 -37.81%
2003 6.33 -5.53%
2002 6.70 -16.24%
2001 7.99 -42.42%
2000 13.88 0.00%
同業他社のP/B比率
企業 P/B比率 P/B比率の差
31.0864 288.19%
US
7.4766 -6.64%
US
-74.4354 -1,029.51%
US
8.4776 5.86%
CH
6.754 -15.66%
CH